Pharmacology of a new low molecular weight dermatan sulphate (Desmin) in healthy volunteers: repeated daily intramuscular administration of 400 mg for a week.

Dettori, A G; Zamboni, V; Manotti, C; Canova, N; Barbanti, M; Palazzini, E

Main content 1 Search 2 Footer 3

+A A -A High contrast

VHL Regional Portal

Information and Knowledge for Health

Advanced Search EVID@Easy

Pharmacology of a new low molecular weight dermatan sulphate (Desmin) in healthy volunteers: repeated daily intramuscular administration of 400 mg for a week.

Dettori, A G; Zamboni, V; Manotti, C; Canova, N; Barbanti, M; Palazzini, E.

Affiliation

Dettori AG; Centre for Haemostatic Diseases, Ospedale Maggiore, Parma, Italy.

Thromb Res ; 83(1): 103-9, 1996 Jul 01.

Article in En | MEDLINE | ID: mdl-8837309

Subject(s)

Search on Google

Add to My VHL

Print

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Dermatan Sulfate / Fibrinolytic Agents Limits: Adult / Female / Humans / Male Language: En Journal: Thromb Res Year: 1996 Document type: Article Affiliation country:

Search on Google

Add to My VHL

Print

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Dermatan Sulfate / Fibrinolytic Agents Limits: Adult / Female / Humans / Male Language: En Journal: Thromb Res Year: 1996 Document type: Article Affiliation country: